Combined lung transplantation and percutaneous septal defect closure for end-stage atrial septal defect associated pulmonary arterial hypertension
ConclusionDLT followed by percutaneous ASD closure is an efficient therapeutic approach in patients with end-stage ASD associated PAH that may offer an alternative option to HLT.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
More News: Atrial Septal Defect | Bone Graft | Cardiology | Cardiovascular | Heart | Heart Transplant | Hole in the Heart | Hypertension | Lung Transplant | Respiratory Medicine | Transplant Surgery | Transplants